Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tucaresol in HIV-1 infected adults
NCT00343941Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tucaresol in human immunodeficiency virus infection (HIV), sponsored by GSK. Started Nov 2004; status: completed.
02
Drugs
tucaresol
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00343941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00343941.